LensAR Inc.
LensAR Inc. of Orlando, Fla., has received 510(k) clearance from the FDA for its next-generation LensAR Laser System for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery. The regulatory action covers the new system, which is in final preparation for commercial launch in the US. The system combines the latest laser technology with product features intended to improve surgeon and patient interactions with it. Enhancements include 3-D imaging measurement and beam-guided delivery that generates a personalized surgical treatment plan.
LATEST NEWS
- Quantinuum Launches 56-Qubit Quantum Computer: Week in Brief: 6/7/2024
Jun 7, 2024
- Atom Computing Lands Investment, Expands Overseas
Jun 7, 2024
- Optogenetic Stimulation Enables Fatigue-Resistant Muscle Control
Jun 6, 2024
- Quandela Launches Pilot Line for Qubit Devices
Jun 6, 2024
- Lattice Semiconductor Adds Interim CEO
Jun 6, 2024
- On-Chip Microcomb Laser Provides Greater Control
Jun 5, 2024
- Flexible, Stretchable Device Addresses Tuning Limitations in Structural Color
Jun 5, 2024
- Fusion Startup Xcimer Raises $100M, Plans Laser Prototype
Jun 4, 2024